AWAIS RIAZ MD
Prescription History 1205926821
Psychiatry & Neurology - Neurology in Salt Lake City, UT


Quality Rating: 92.06 out of 100 score

NPI Status: Active since October 13, 2006

Contact Information

50 N MEDICAL DR
SALT LAKE CITY, UT
ZIP 84132
Phone: (801) 585-6387

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for AWAIS RIAZ MD, an active Neurology specialist practicing in Salt Lake City, UT. Our medical registry currently tracks 22 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 626 documented patient claims. Among these therapy options, the most frequently utilized medication is Levetiracetam, which accounts for 104 claims alone.


Briviact

Generic Formulation: BrivaracetamSpecialty: Neuropsychiatry
Provider Metrics Summary
Total Claims 14
30-Day Fills 14.0
Days Supply 403
UT State Average Benchmarks
Peer Average Claims30.0
Peer Average 30-Day Fills33.1
Peer Average Days Supply944
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 53.3% less volume than the regional standard for practitioners inside UT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $17,696.68 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,264.05

State Avg Cost Per Claim

$1,415.86

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Brivaracetam is used to treat seizures (epilepsy).

Clobazam

Generic Formulation: ClobazamSpecialty: Neuropsychiatry
Provider Metrics Summary
Total Claims 13
30-Day Fills 13.0
Days Supply 364
UT State Average Benchmarks
Peer Average Claims42.0
Peer Average 30-Day Fills47.4
Peer Average Days Supply1,298
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 69.0% less volume than the regional standard for practitioners inside UT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $8,988.70 across this reporting matrix range.

Provider Avg Cost Per Claim

$691.44

State Avg Cost Per Claim

$164.77

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzodiazepine derivative that is a long-acting GABA-A RECEPTOR agonist. It is used as an antiepileptic in the treatment of SEIZURES, including seizures associated with LENNOX-GASTAUT SYNDROME. It is also used as an anxiolytic, for the short-term treatment of acute ANXIETY.

Therapeutic Applications

This medication is used with other medications to help control seizures. It belongs to a class of medications called benzodiazepines, which act on the brain and nerves (central nervous system) to produce a calming effect. This drug works by enhancing the effects of a certain natural chemical in the body (GABA).

Clonazepam

Generic Formulation: ClonazepamSpecialty: Neuropsychiatry
Provider Metrics Summary
Total Claims 26
30-Day Fills 30.0
Days Supply 844
UT State Average Benchmarks
Peer Average Claims44.0
Peer Average 30-Day Fills48.4
Peer Average Days Supply1,361
Conservative Utilization

This provider writes prescriptions for this formulation 40.9% less frequently than the standard regional baseline metric for practitioners inside UT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $217.97 across this reporting matrix range.

Provider Avg Cost Per Claim

$8.38

State Avg Cost Per Claim

$8.53

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An anticonvulsant used for several types of seizures, including myotonic or atonic seizures, photosensitive epilepsy, and absence seizures, although tolerance may develop. It is seldom effective in generalized tonic-clonic or partial seizures. The mechanism of action appears to involve the enhancement of GAMMA-AMINOBUTYRIC ACID receptor responses.

Therapeutic Applications

Clonazepam is used to prevent and control seizures. This medication is known as an anticonvulsant or antiepileptic drug. It is also used to treat panic attacks. Clonazepam works by calming your brain and nerves. It belongs to a class of drugs called benzodiazepines.

Depakote

Generic Formulation: Divalproex SodiumSpecialty: Neuropsychiatry
Provider Metrics Summary
Total Claims 18
30-Day Fills 18.0
Days Supply 487
UT State Average Benchmarks
Peer Average Claims12.0
Peer Average 30-Day Fills13.1
Peer Average Days Supply393
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 50.0% more claims than the standard regional baseline profile for UT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $13,441.10 across this reporting matrix range.

Provider Avg Cost Per Claim

$746.73

State Avg Cost Per Claim

$636.01

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.

Therapeutic Applications

This medication is used to treat seizure disorders, certain psychiatric conditions (manic phase of bipolar disorder), and to prevent migraine headaches. It works by restoring the balance of certain natural substances (neurotransmitters) in the brain.

Dilantin

Generic Formulation: Phenytoin Sodium ExtendedSpecialty: Neuropsychiatry
Provider Metrics Summary
Total Claims 14
30-Day Fills 14.0
Days Supply 328
UT State Average Benchmarks
Peer Average Claims15.0
Peer Average 30-Day Fills18.5
Peer Average Days Supply496
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across UT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,947.04 across this reporting matrix range.

Provider Avg Cost Per Claim

$139.07

State Avg Cost Per Claim

$134.96

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An anticonvulsant that is used to treat a wide variety of seizures. It is also an anti-arrhythmic and a muscle relaxant. The mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. The mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. Phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs.

Therapeutic Applications

Phenytoin is used to prevent and control seizures (also called an anticonvulsant or antiepileptic drug). It works by reducing the spread of seizure activity in the brain.

Divalproex Sodium

Generic Formulation: Divalproex SodiumSpecialty: Neuropsychiatry
Provider Metrics Summary
Total Claims 18
30-Day Fills 31.7
Days Supply 919
UT State Average Benchmarks
Peer Average Claims37.0
Peer Average 30-Day Fills44.2
Peer Average Days Supply1,201
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 51.4% less volume than the regional standard for practitioners inside UT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,486.36 across this reporting matrix range.

Provider Avg Cost Per Claim

$82.58

State Avg Cost Per Claim

$49.02

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.

Therapeutic Applications

This medication is used to treat seizure disorders, certain psychiatric conditions (manic phase of bipolar disorder), and to prevent migraine headaches. It works by restoring the balance of certain natural substances (neurotransmitters) in the brain.

Fycompa

Generic Formulation: PerampanelSpecialty: Neuropsychiatry
Provider Metrics Summary
Total Claims 12
30-Day Fills 12.0
Days Supply 360
UT State Average Benchmarks
Peer Average Claims20.0
Peer Average 30-Day Fills21.2
Peer Average Days Supply626
Conservative Utilization

This provider writes prescriptions for this formulation 40.0% less frequently than the standard regional baseline metric for practitioners inside UT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $14,851.08 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,237.59

State Avg Cost Per Claim

$1,154.86

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Perampanel is used to treat certain types of seizures (including focal and generalized tonic-clonic seizures). Perampanel belongs to a class of drugs known as anticonvulsants.

Keppra

Generic Formulation: LevetiracetamSpecialty: Neuropsychiatry
Provider Metrics Summary
Total Claims 19
30-Day Fills 19.0
Days Supply 550
UT State Average Benchmarks
Peer Average Claims21.0
Peer Average 30-Day Fills21.4
Peer Average Days Supply629
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across UT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $44,032.62 across this reporting matrix range.

Provider Avg Cost Per Claim

$2,317.51

State Avg Cost Per Claim

$1,386.87

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A pyrrolidinone and acetamide derivative that is used primarily for the treatment of SEIZURES and some movement disorders, and as a nootropic agent.

Therapeutic Applications

Levetiracetam is used to treat seizures (epilepsy). It belongs to a class of drugs known as anticonvulsants. Levetiracetam may decrease the number of seizures you have.

Lacosamide

Generic Formulation: LacosamideSpecialty: Neuropsychiatry
Provider Metrics Summary
Total Claims 75
30-Day Fills 81.0
Days Supply 2,386
UT State Average Benchmarks
Peer Average Claims32.0
Peer Average 30-Day Fills37.5
Peer Average Days Supply1,042
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 134.4% higher than the standard regional baseline profile for UT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $10,645.66 across this reporting matrix range.

Provider Avg Cost Per Claim

$141.94

State Avg Cost Per Claim

$282.39

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An acetamide derivative that acts as a blocker of VOLTAGE-GATED SODIUM CHANNELS. It is used as an anticonvulsant, for adjunctive or monotherapy, in the treatment of PARTIAL SEIZURES.

Therapeutic Applications

Lacosamide is used to prevent and control seizures. It is an anticonvulsant or antiepileptic drug. It works by reducing the spread of seizure activity in the brain.

Lamictal

Generic Formulation: LamotrigineSpecialty: Neuropsychiatry
Provider Metrics Summary
Total Claims 14
30-Day Fills 19.1
Days Supply 572
UT State Average Benchmarks
Peer Average Claims20.0
Peer Average 30-Day Fills23.8
Peer Average Days Supply702
Conservative Utilization

This provider writes prescriptions for this formulation 30.0% less frequently than the standard regional baseline metric for practitioners inside UT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $49,258.93 across this reporting matrix range.

Provider Avg Cost Per Claim

$3,518.50

State Avg Cost Per Claim

$1,668.51

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A phenyltriazine compound, sodium and calcium channel blocker that is used for the treatment of SEIZURES and BIPOLAR DISORDER.

Therapeutic Applications

Lamotrigine is used alone or with other medications to prevent and control seizures. It may also be used to help prevent the extreme mood swings of bipolar disorder in adults. Lamotrigine is known as an anticonvulsant or antiepileptic drug. It is thought to work by restoring the balance of certain natural substances in the brain. This drug is not approved for use in children younger than 2 years due to an increased risk of side effects (such as infections).

Lamictal Xr

Generic Formulation: LamotrigineSpecialty: Neuropsychiatry
Provider Metrics Summary
Total Claims 12
30-Day Fills 14.0
Days Supply 420
UT State Average Benchmarks
Peer Average Claims13.0
Peer Average 30-Day Fills16.0
Peer Average Days Supply480
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across UT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $54,925.46 across this reporting matrix range.

Provider Avg Cost Per Claim

$4,577.12

State Avg Cost Per Claim

$3,232.99

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A phenyltriazine compound, sodium and calcium channel blocker that is used for the treatment of SEIZURES and BIPOLAR DISORDER.

Therapeutic Applications

Lamotrigine is used alone or with other medications to prevent and control seizures. It may also be used to help prevent the extreme mood swings of bipolar disorder in adults. Lamotrigine is known as an anticonvulsant or antiepileptic drug. It is thought to work by restoring the balance of certain natural substances in the brain. This drug is not approved for use in children younger than 2 years due to an increased risk of side effects (such as infections).

Lamotrigine

Generic Formulation: LamotrigineSpecialty: Neuropsychiatry
Provider Metrics Summary
Total Claims 66
30-Day Fills 97.1
Days Supply 2,829
UT State Average Benchmarks
Peer Average Claims38.0
Peer Average 30-Day Fills62.6
Peer Average Days Supply1,814
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 73.7% higher than the standard regional baseline profile for UT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,640.59 across this reporting matrix range.

Provider Avg Cost Per Claim

$24.86

State Avg Cost Per Claim

$19.17

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A phenyltriazine compound, sodium and calcium channel blocker that is used for the treatment of SEIZURES and BIPOLAR DISORDER.

Therapeutic Applications

Lamotrigine is used alone or with other medications to prevent and control seizures. It may also be used to help prevent the extreme mood swings of bipolar disorder in adults. Lamotrigine is known as an anticonvulsant or antiepileptic drug. It is thought to work by restoring the balance of certain natural substances in the brain. This drug is not approved for use in children younger than 2 years due to an increased risk of side effects (such as infections).

Levetiracetam

Generic Formulation: LevetiracetamSpecialty: Neuropsychiatry
Provider Metrics Summary
Total Claims 104
30-Day Fills 172.3
Days Supply 5,138
UT State Average Benchmarks
Peer Average Claims35.0
Peer Average 30-Day Fills55.2
Peer Average Days Supply1,569
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 197.1% higher than the standard regional baseline profile for UT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $8,152.90 across this reporting matrix range.

Provider Avg Cost Per Claim

$78.39

State Avg Cost Per Claim

$42.45

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A pyrrolidinone and acetamide derivative that is used primarily for the treatment of SEIZURES and some movement disorders, and as a nootropic agent.

Therapeutic Applications

Levetiracetam is used to treat seizures (epilepsy). It belongs to a class of drugs known as anticonvulsants. Levetiracetam may decrease the number of seizures you have.

Lorazepam

Generic Formulation: LorazepamSpecialty: Neuropsychiatry
Provider Metrics Summary
Total Claims 30
30-Day Fills 30.0
Days Supply 740
UT State Average Benchmarks
Peer Average Claims38.0
Peer Average 30-Day Fills41.8
Peer Average Days Supply1,100
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across UT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $220.28 across this reporting matrix range.

Provider Avg Cost Per Claim

$7.34

State Avg Cost Per Claim

$7.95

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.

Therapeutic Applications

This medication is used to treat serious seizures that do not stop (status epilepticus). It is also used before surgeries or procedures to cause drowsiness, decrease anxiety, and cause forgetfulness about the procedure or surgery. Lorazepam belongs to a class of medications called benzodiazepines, which produce a calming effect on the brain and nerves (central nervous system). It is thought to work by increasing the effect of a certain natural chemical (GABA) in the brain.

Oxcarbazepine

Generic Formulation: OxcarbazepineSpecialty: Neuropsychiatry
Provider Metrics Summary
Total Claims 29
30-Day Fills 37.0
Days Supply 1,085
UT State Average Benchmarks
Peer Average Claims25.0
Peer Average 30-Day Fills35.5
Peer Average Days Supply1,001
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across UT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,415.58 across this reporting matrix range.

Provider Avg Cost Per Claim

$48.81

State Avg Cost Per Claim

$68.65

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A carbamazepine derivative that acts as a voltage-gated sodium channel blocker. It is used for the treatment of PARTIAL SEIZURES with or without secondary generalization. It is also an inducer of CYTOCHROME P-450 CYP3A4.

Therapeutic Applications

Oxcarbazepine is used alone or with other medications to treat seizure disorders (epilepsy).

Phenytoin Sodium Extended

Generic Formulation: Phenytoin Sodium ExtendedSpecialty: Neuropsychiatry
Provider Metrics Summary
Total Claims 19
30-Day Fills 33.0
Days Supply 990
UT State Average Benchmarks
Peer Average Claims17.0
Peer Average 30-Day Fills24.7
Peer Average Days Supply698
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across UT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $892.76 across this reporting matrix range.

Provider Avg Cost Per Claim

$46.99

State Avg Cost Per Claim

$40.35

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Phenytoin is used to prevent and control seizures (also called an anticonvulsant or antiepileptic drug). It works by reducing the spread of seizure activity in the brain.

Sertraline Hcl

Generic Formulation: Sertraline HclSpecialty: Neuropsychiatry
Provider Metrics Summary
Total Claims 15
30-Day Fills 21.0
Days Supply 630
UT State Average Benchmarks
Peer Average Claims52.0
Peer Average 30-Day Fills105.9
Peer Average Days Supply3,114
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 71.2% less volume than the regional standard for practitioners inside UT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $139.06 across this reporting matrix range.

Provider Avg Cost Per Claim

$9.27

State Avg Cost Per Claim

$13.79

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Sertraline is used to treat depression, panic attacks, obsessive compulsive disorder, post-traumatic stress disorder, social anxiety disorder (social phobia), and a severe form of premenstrual syndrome (premenstrual dysphoric disorder). This medication may improve your mood, sleep, appetite, and energy level and may help restore your interest in daily living. It may decrease fear, anxiety, unwanted thoughts, and the number of panic attacks. It may also reduce the urge to perform repeated tasks (compulsions such as hand-washing, counting, and checking) that interfere with daily living. Sertraline is known as a selective serotonin reuptake inhibitor (SSRI). It works by helping to restore the balance of a certain natural substance (serotonin) in the brain.

Tegretol

Generic Formulation: CarbamazepineSpecialty: Neuropsychiatry
Provider Metrics Summary
Total Claims 17
30-Day Fills 25.0
Days Supply 750
UT State Average Benchmarks
Peer Average Claims13.0
Peer Average 30-Day Fills15.0
Peer Average Days Supply445
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 30.8% more claims than the standard regional baseline profile for UT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $4,998.62 across this reporting matrix range.

Provider Avg Cost Per Claim

$294.04

State Avg Cost Per Claim

$431.43

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.

Therapeutic Applications

Carbamazepine is used to prevent and control seizures. This medication is known as an anticonvulsant or anti-epileptic drug. It is also used to relieve certain types of nerve pain (such as trigeminal neuralgia). This medication works by reducing the spread of seizure activity in the brain and restoring the normal balance of nerve activity.

Topiramate

Generic Formulation: TopiramateSpecialty: Neuropsychiatry
Provider Metrics Summary
Total Claims 33
30-Day Fills 35.0
Days Supply 1,020
UT State Average Benchmarks
Peer Average Claims28.0
Peer Average 30-Day Fills47.9
Peer Average Days Supply1,392
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across UT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $343.34 across this reporting matrix range.

Provider Avg Cost Per Claim

$10.40

State Avg Cost Per Claim

$19.63

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A sulfamate-substituted fructose analog that was originally identified as a hypoglycemic agent. It is used for the treatment of EPILEPSY and MIGRAINE DISORDERS, and may also promote weight loss.

Therapeutic Applications

Topiramate is used alone or with other medications to prevent and control seizures (epilepsy). This medication is also used to prevent migraine headaches and decrease how often you get them. Topiramate will not treat a migraine headache once it occurs. If you get a migraine headache, treat it as directed by your doctor (such as by taking pain medication, lying down in a dark room). Topiramate is known as an anticonvulsant or antiepileptic drug.

Trileptal

Generic Formulation: OxcarbazepineSpecialty: Neuropsychiatry
Provider Metrics Summary
Total Claims 11
30-Day Fills 11.0
Days Supply 309
UT State Average Benchmarks
Peer Average Claims--
Peer Average 30-Day Fills--
Peer Average Days Supply--

Provider Avg Cost Per Claim

$914.05

State Avg Cost Per Claim

--

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A carbamazepine derivative that acts as a voltage-gated sodium channel blocker. It is used for the treatment of PARTIAL SEIZURES with or without secondary generalization. It is also an inducer of CYTOCHROME P-450 CYP3A4.

Therapeutic Applications

Oxcarbazepine is used alone or with other medications to treat seizure disorders (epilepsy).

Vimpat

Generic Formulation: LacosamideSpecialty: Neuropsychiatry
Provider Metrics Summary
Total Claims 20
30-Day Fills 20.0
Days Supply 600
UT State Average Benchmarks
Peer Average Claims31.0
Peer Average 30-Day Fills35.3
Peer Average Days Supply977
Conservative Utilization

This provider writes prescriptions for this formulation 35.5% less frequently than the standard regional baseline metric for practitioners inside UT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $21,990.16 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,099.51

State Avg Cost Per Claim

$1,078.04

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An acetamide derivative that acts as a blocker of VOLTAGE-GATED SODIUM CHANNELS. It is used as an anticonvulsant, for adjunctive or monotherapy, in the treatment of PARTIAL SEIZURES.

Therapeutic Applications

Lacosamide is used to prevent and control seizures. It is an anticonvulsant or antiepileptic drug. It works by reducing the spread of seizure activity in the brain.

Zonisamide

Generic Formulation: ZonisamideSpecialty: Neuropsychiatry
Provider Metrics Summary
Total Claims 47
30-Day Fills 59.0
Days Supply 1,724
UT State Average Benchmarks
Peer Average Claims29.0
Peer Average 30-Day Fills46.0
Peer Average Days Supply1,332
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 62.1% higher than the standard regional baseline profile for UT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $3,891.74 across this reporting matrix range.

Provider Avg Cost Per Claim

$82.80

State Avg Cost Per Claim

$46.11

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.

Therapeutic Applications

Zonisamide is used with other medications to prevent and control seizures (epilepsy). Zonisamide is a sulfonamide anticonvulsant and a carbonic anhydrase inhibitor. It is unknown how zonisamide works to prevent seizures.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like AWAIS RIAZ MD provides transparency into local medical care patterns within Salt Lake City, UT.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Neurology** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.